![](/img/cover-not-exists.png)
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma
Huijts, Charlotte M., Werter, Inge M., Lougheed, Sinéad M., Goedegebuure, Ruben S., van Herpen, Carla M., Hamberg, Paul, Tascilar, Metin, Haanen, John B., Verheul, Henk M., de Gruijl, Tanja D., van deLanguage:
english
Journal:
Cancer Immunology, Immunotherapy
DOI:
10.1007/s00262-018-2248-3
Date:
November, 2018
File:
PDF, 1.06 MB
english, 2018